| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-15 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-09 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.27 | 6e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 6e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.31 | 9e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |